BMS actively collaborates with a variety of stakeholders, including academic institutions, research organizations, and other pharmaceutical companies. These collaborations aim to accelerate the discovery and development of new cancer treatments. For instance, BMS has partnered with leading research institutions to explore novel biomarkers and therapeutic targets.
